AJPM focus最新文献

{"title":"Health- and Non–Health-Related Corporate Social Responsibility Statements in Top Selling Restaurant Chains in the U.S. Between 2012 and 2018: A Content Analysis","authors":"Megan P. Mueller PhD ,&nbsp;Alyssa Leib MS ,&nbsp;Deborah C. Glik PhD ,&nbsp;Sara N. Bleich PhD ,&nbsp;Jason Wang PhD ,&nbsp;Catherine M. Crespi PhD ,&nbsp;May C. Wang DrPH","doi":"10.1016/j.focus.2024.100295","DOIUrl":"10.1016/j.focus.2024.100295","url":null,"abstract":"<div><h3>Introduction</h3><div>The aim of this study was to understand the prevalence and content of corporate social responsibility statements in the top-selling chain restaurants between 2012 and 2018 to inform the ways restaurants can impact population health.</div></div><div><h3>Methods</h3><div>The study used a web scraping technique to abstract relevant text information (<em>n</em>=6,369 text sections that contained possible corporate social responsibility statements or thematically coded portions of the text section) from the archived web pages of the 96 top-selling chain restaurants. Content analysis was used to identify key themes in corporate social responsibility statements across restaurants and over time. All data were abstracted, and analyses were completed between November 2019 and November 2023.</div></div><div><h3>Results</h3><div>The majority of restaurants (68.8%) included a corporate social responsibility statement on their web pages between 2012 and 2018, and approximately half of the restaurants featured a health-related corporate social responsibility statement (51.0%). There were increases in corporate social responsibility statements by chain restaurants over the study period from 186 corporate social responsibility statements in 2012 to 1,218 corporate social responsibility statements in 2018, with most statements focused on philanthropy (37.1% of coded statements), community activities that were not health related (18.4% of coded statements), and sustainability initiatives (18.3% of coded statements). Only one quarter (24.4%) of these corporate social responsibility statements were health related, and many were vague in nature (only 28% of the eligible statements could be coded by theme).</div></div><div><h3>Conclusions</h3><div>There is a need for more actionable health-focused initiatives in the corporate social responsibility statements for chain restaurants. Public health initiatives that engage with the restaurant industry should work to promote corporate social responsibility statements that are in line with other collective positions around improving health and reducing diet-related disease.</div></div>","PeriodicalId":72142,"journal":{"name":"AJPM focus","volume":"4 1","pages":"Article 100295"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11758830/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143048823","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"The Association Between a Summary Measure of Social Determinants of Health/Health Equity and Cardiovascular Disease Burden Among Mississippi Adults","authors":"Vincent L. Mendy DrPH, MPH, CPH ,&nbsp;Tawandra L. Rowell-Cunsolo PHD ,&nbsp;Byambaa Enkhmaa MD, PHD","doi":"10.1016/j.focus.2024.100297","DOIUrl":"10.1016/j.focus.2024.100297","url":null,"abstract":"<div><h3>Introduction</h3><div>Cardiovascular disease is the leading cause of death among Mississippi adults. Social determinants of health are significant contributors to cardiovascular disease risk and associated mortality as well as health disparities. The authors examined the association between a summary measure of social determinants of health and cardiovascular disease among Mississippi adults.</div></div><div><h3>Methods</h3><div>Using the social determinants of health and health equity module data from 3,994 respondents to the 2022 Mississippi Behavioral Risk Factor Surveillance System survey, the authors conducted multivariable logistic regression models to examine the association between cardiovascular disease and a social determinants of health/health equity summary measure.</div></div><div><h3>Results</h3><div>Participants who received food stamps or were enrolled in the Supplemental Nutrition Assistance Program (AOR=2.28; 95% CI=1.35, 3.86), experienced food insecurity (AOR=1.74; 95% CI=1.08, 2.79), and experienced mental distress (AOR=2.39; 95% CI=1.54, 3.73) had significantly higher odds of cardiovascular disease than their counterparts without any of these factors. Mississippi adults experiencing 4 or more of social determinants of health/health equity risk factors had a 2.56 (AOR=2.56; 95% CI=1.49, 4.41) higher odds of cardiovascular disease than those experiencing no social determinants of health/health equity risk factors.</div></div><div><h3>Conclusions</h3><div>Mississippi adults with 4 or more social determinants of health/health equity risk factors had significantly higher odds of cardiovascular disease than those with no social determinants of health/health equity risk factors. These findings highlight the importance of social determinants of health/health equity factors in cardiovascular disease burden and suggest that interventions targeted at individuals with multiple social determinants of health/health equity risk factors are needed to reduce the high burden of cardiovascular disease among Mississippi adults.</div></div>","PeriodicalId":72142,"journal":{"name":"AJPM focus","volume":"4 1","pages":"Article 100297"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11714402/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142959874","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Determining Filipinos’ Preferences for Colorectal Cancer Screening Tests: Insights From a Choice-Based Conjoint Analysis","authors":"Austin Crochetiere MD ,&nbsp;Marie Lauzon MS ,&nbsp;Antwon Chaplin BA ,&nbsp;Christopher V. Almario MD, MSHPM","doi":"10.1016/j.focus.2024.100300","DOIUrl":"10.1016/j.focus.2024.100300","url":null,"abstract":"<div><h3>Introduction</h3><div>Filipinos in the U.S. have worse colorectal cancer screening rates and outcomes than non-Hispanic Whites, despite 85% of Filipinos being proficient in English and having insurance rates, education, and incomes that exceed those of the general population. To begin to address this disparity, the authors used conjoint analysis—a method that assesses complex decision making—to better understand Filipinos’ preferences for the different colorectal cancer screening test options.</div></div><div><h3>Methods</h3><div>The authors conducted a conjoint analysis survey among unscreened Filipinos aged ≥40 years at average risk for colorectal cancer to determine the relative importance of screening test attributes in their decision making (e.g., modality, effectiveness at reducing colorectal cancer risk, bowel prep). The authors also performed simulations to estimate the proportion of people who would prefer to do an annual fecal immunochemical test or colonoscopy every 10 years for their screening.</div></div><div><h3>Results</h3><div>Overall, 105 Filipinos completed the survey; most respondents were female (74.3%) and aged 40–49 years (84.8%). The authors observed that test modality was the most important factor in respondents’ decision making. After conducting simulations using the conjoint analysis data, the authors noted that 70 (66.7%) Filipinos preferred to do an annual fecal immunochemical test for their screening, whereas 35 (33.3%) wanted to do a colonoscopy every 10 years.</div></div><div><h3>Conclusions</h3><div>The authors found that 2 in 3 Filipinos prefer fecal immunochemical test to colonoscopy for their colorectal cancer screening. To address colorectal cancer disparities in the Filipino community, investigators, health systems, public health agencies, and community organizations need to develop culturally tailored, sustainable interventions, and such programs may want to focus on improving education on and access to fecal immunochemical test.</div></div>","PeriodicalId":72142,"journal":{"name":"AJPM focus","volume":"4 1","pages":"Article 100300"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11731454/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142985412","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Demographic Characteristics Associated With Adolescent Receipt of Provider E-Cigarette Screening and Advice and the Impact on Harm Perception","authors":"John S. Acosta-Peñaloza MS,&nbsp;Karen W. Geletko MPH,&nbsp;Jon Mills PhD","doi":"10.1016/j.focus.2024.100309","DOIUrl":"10.1016/j.focus.2024.100309","url":null,"abstract":"<div><h3>Introduction</h3><div>The growing prevalence of E-cigarette use among adolescents is alarming because it increases the probability of persistent tobacco use and addiction to nicotine. Healthcare providers are in a unique position to influence their patients’ use of E-cigarettes. The purpose of the study is to determine the frequency at which providers screen adolescents for E-cigarette use and advise against use during healthcare visits. The study also examines associations between provider intervention and adolescent harm perception.</div></div><div><h3>Methods</h3><div>Using data from the 2021 National Youth Tobacco Survey, the authors examined provider E-cigarette screening and advice to not use from 16,910 participants who self-reported receiving medical care within the preceding year. Multivariable logistic regression models were used to assess whether the odds of provider intervention varied by age, sex, and race/ethnicity and whether receiving provider intervention was associated with a likelihood for harm perception.</div></div><div><h3>Results</h3><div>Provider intervention was more likely among those aged 13–18 years, who are male, and who are White and/or non-Hispanic (<em>p</em>&lt;0.001). The authors found no association between provider intervention and increased harm perception of E-cigarettes; however, provider intervention was associated with the belief that E-cigarettes are equally or more addictive than cigarettes (<em>p</em>&lt;0.0001).</div></div><div><h3>Conclusions</h3><div>Study findings emphasize the significance of addressing disparities in E-cigarette use and healthcare provider intervention among minority adolescents, underscoring the need for healthcare providers to be thorough in screening for E-cigarette use and providing appropriate cessation support.</div></div>","PeriodicalId":72142,"journal":{"name":"AJPM focus","volume":"4 1","pages":"Article 100309"},"PeriodicalIF":0.0,"publicationDate":"2025-02-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11758822/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143048808","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Cigarette Smoking Patterns Among Racial and Ethnic Groups With Chronic Lung Diseases During the COVID-19 Pandemic","authors":"Vijaya L. Seegulam MPH ,&nbsp;Caretia J. Washington BS ,&nbsp;Parvathy P. Surendran BPT ,&nbsp;Alyssa M. Falise PhD, MSPH ,&nbsp;Diana Gomez-Manjarres MD ,&nbsp;Catalina Lopez-Quintero MD, MPH, PhD","doi":"10.1016/j.focus.2024.100310","DOIUrl":"10.1016/j.focus.2024.100310","url":null,"abstract":"&lt;div&gt;&lt;h3&gt;Introduction&lt;/h3&gt;&lt;div&gt;Chronic obstructive pulmonary disease and asthma are significant respiratory conditions that contribute to substantial morbidity and mortality globally. Chronic obstructive pulmonary disease remains the third most prevalent cause of death worldwide, with 90% of chronic obstructive pulmonary disease deaths attributed to combustible cigarette smoking. Asthma, although often less fatal, leads to considerable health burdens, particularly among marginalized populations who are at higher risk for both more severe chronic obstructive pulmonary disease and asthma outcomes. This study investigates the association between race/ethnicity and current cigarette smoking among adults diagnosed with chronic obstructive pulmonary disease and/or asthma in the U.S. before, during, and after the COVID-19 pandemic.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Methods&lt;/h3&gt;&lt;div&gt;The authors analyzed data from 10,763 adults (aged ≥40 years) with a history of chronic obstructive pulmonary disease and/or asthma surveyed in the 2019, 2021, and 2023 National Health Interview Survey. The authors estimated predicted probabilities derived from multiple logistic regression and negative binomial regression models to examine changes in (1) the prevalence of current cigarette smoking in the target population, (2) the mean number of days of cigarette smoking in the past 30 days, and (3) the mean number of cigarettes smoked in the past 30 days across racial/ethnic subgroups and prepandemic, pandemic, and postpandemic periods.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Results&lt;/h3&gt;&lt;div&gt;Current cigarette smoking was reported by about one fifth (20%) of U.S. adults diagnosed with chronic obstructive pulmonary disease and asthma. Among them, the mean number of days of cigarette smoking in the past 30 days was 27 days, and the mean number of cigarettes smoked in the past 30 days was 14. Hispanic individuals had the lowest prepandemic rates of current cigarette smoking (10.5%); however, it was the only racial/ethnic group showing a significant change during the pandemic, with rates increasing to 14.9% during the pandemic. Non-Hispanic White individuals, who showed the highest rates of current cigarette smoking (21.1%) during the pandemic, were the only racial/ethnic group showing a significant decline in the postpandemic period (19.8%). No significant changes were observed in the mean number of days or cigarettes smoked in the past 30 days, except for a marginally significant increase in cigarette consumption among non-Hispanic Black individuals.&lt;/div&gt;&lt;/div&gt;&lt;div&gt;&lt;h3&gt;Conclusions&lt;/h3&gt;&lt;div&gt;These analyses suggest that the pandemic had a differential impact on the rates of current smoking across racial/ethnic subgroups in adults with chronic obstructive pulmonary disease and/or asthma, with a detrimental effect in Hispanic individuals and an improvement among non-Hispanic White individuals. Given the dangers of smoking in chronic lung conditions, future research should investigate the factors behind these to de","PeriodicalId":72142,"journal":{"name":"AJPM focus","volume":"4 3","pages":"Article 100310"},"PeriodicalIF":0.0,"publicationDate":"2024-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143140256","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Heterogeneity of the Association Between Obesity and COVID-19 Mortality and the Roles of Policy Interventions: U.S. National-Level Analysis","authors":"Nabin Bhandari MS ,&nbsp;Joel M. Cuffey PhD ,&nbsp;Ruiqing Miao PhD ,&nbsp;David Zilberman PhD","doi":"10.1016/j.focus.2024.100312","DOIUrl":"10.1016/j.focus.2024.100312","url":null,"abstract":"<div><div>This article examines the heterogeneity of the association between obesity and COVID-19 mortality across various dimensions, including COVID-19 vaccination rates, mask mandates, gathering restrictions, and household income. Using multivariate regression analysis on U.S. county-level data over 2020–2021, the authors found that county-level adult obesity rates were positively associated with COVID-19 death rates. The results suggest that on average, a 10-percentage-point decrease in adult obesity rate is associated with a decrease in COVID-19 deaths by 4.79%–5.98% in the U.S. Considering that the average adult obesity rate in the U.S. is higher than the global average, this finding may explain why deaths due to COVID-19 were disproportionately large in the U.S. In addition, the authors found that association between obesity and the COVID-19 death rate is much more pronounced in groups with low vaccination rates, weak mask mandates, loose gathering restrictions, or low household incomes, indicating the importance of COVID-19 response policies and income to people with obesity facing a pandemic. The study results contribute to policy discussions surrounding preparation for COVID-19–like pandemics. Food policies and health promotion strategies that encourage physical well-being to reduce obesity prevalence may help reduce mortality in future pandemics.</div></div>","PeriodicalId":72142,"journal":{"name":"AJPM focus","volume":"4 3","pages":"Article 100312"},"PeriodicalIF":0.0,"publicationDate":"2024-12-04","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143140254","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Editorial Board and Journal Information","authors":"","doi":"10.1016/S2773-0654(24)00116-0","DOIUrl":"10.1016/S2773-0654(24)00116-0","url":null,"abstract":"","PeriodicalId":72142,"journal":{"name":"AJPM focus","volume":"3 6","pages":"Article 100298"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142746870","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"2023 Author Acknowledgment and Articles of the Year","authors":"","doi":"10.1016/S2773-0654(24)00117-2","DOIUrl":"10.1016/S2773-0654(24)00117-2","url":null,"abstract":"","PeriodicalId":72142,"journal":{"name":"AJPM focus","volume":"3 6","pages":"Article 100299"},"PeriodicalIF":0.0,"publicationDate":"2024-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142746869","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"E-Cigarette Use and Use of Evidence-Based Smoking Cessation Methods Among American Indian Cigarette Smokers: A Cross-Sectional Analysis","authors":"Ashley L. Comiford DrPH ,&nbsp;Dorothy A. Rhoades MD, MPH ,&nbsp;Justin D. Dvorak PhD ,&nbsp;Kai Ding PhD ,&nbsp;Noah Collins ,&nbsp;Alexandra L. Blair ,&nbsp;Mark P. Doescher MD, MSPH","doi":"10.1016/j.focus.2024.100302","DOIUrl":"10.1016/j.focus.2024.100302","url":null,"abstract":"<div><h3>Introduction</h3><div>Tobacco use is the leading cause of death in the U.S., and American Indian/Alaska Native people have high rates of tobacco-related diseases. Although the U.S. Food and Drug Administration–approved products and evidence-based methods exist for smoking cessation, people who smoke might use E-cigarettes as cessation aids. Whether E-cigarette use is associated with the use of evidence-based methods is unknown, particularly among American Indian/Alaska Native individuals.</div></div><div><h3>Methods</h3><div>Using survey data collected in 2016 from 289 adult American Indian people who smoke and who reported a previous cessation attempt, the authors conducted multivariate logistic regression analyses to assess the associations between E-cigarette use and evidence-based cessation methods. Analyses were performed in 2023.</div></div><div><h3>Results</h3><div>Individuals who currently or formerly used E-cigarettes were significantly more likely to report using nicotine replacement therapy during their last quit attempt than those who did not use E-cigarettes (current versus never AOR=4.6, 95% CI=1.9, 11.9; past versus never AOR=4.6, 95% CI=2.2, 9.8; <em>p</em>&lt;0.001). Current and former E-cigarette use was significantly associated with prescription use in the unadjusted analysis but lost significance in the adjusted analysis (current versus never AOR=3.1, 95% CI=1.0, 10.5; past versus never AOR=2.7, 95% CI=1.1, 7.9; <em>p</em>&gt;0.05). Individuals with current or former use of E-cigarettes were significantly less likely than individuals who never used E-cigarettes to use the cold turkey method (unassisted cessation) (current versus never AOR=0.3, 95% CI=0.2, 0.6; past versus never AOR=0.3, 95% CI=0.1, 0.7; <em>p</em>&lt;0.01).</div></div><div><h3>Conclusions</h3><div>These results suggest that persons who use E-cigarettes are more likely than individuals who do not use E-cigarettes to previously have tried nicotine replacement therapy but less likely to use the cold turkey method. A larger study is needed to determine whether individuals who use E-cigarettes are also more likely to have tried prescription medication for smoking cessation. Whether E-cigarette use impedes or encourages the use of evidence-based cessation methods is unknown.</div></div>","PeriodicalId":72142,"journal":{"name":"AJPM focus","volume":"4 2","pages":"Article 100302"},"PeriodicalIF":0.0,"publicationDate":"2024-11-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143348427","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Disparities in COVID-19 Vaccine Uptake Among Pregnant People in a Diverse Urban Population With High Vaccine Acceptance","authors":"Christine A. Blauvelt MD ,&nbsp;Maura Jones Pullins MD ,&nbsp;Stephanie L. Gaw MD, PhD","doi":"10.1016/j.focus.2024.100303","DOIUrl":"10.1016/j.focus.2024.100303","url":null,"abstract":"<div><h3>Introduction</h3><div>This study's objective was to compare COVID-19 vaccination rates between pregnant individuals in San Francisco and the city's similarly aged population and to identify the factors associated with vaccine uptake in the pregnant population.</div></div><div><h3>Methods</h3><div>This was a retrospective cohort study of all patients delivering at 2 hospitals in San Francisco from March 15, 2021, to October 15, 2021. Reference COVID-19 vaccination rates for San Francisco were obtained from the California Immunization Registry. The primary outcome was completion of a COVID-19 vaccine series among pregnant individuals compared with that in the San Francisco general population aged 18–45 years. Secondary outcomes included factors associated with COVID-19 vaccination among pregnant people.</div></div><div><h3>Results</h3><div>Of 2,294 pregnant individuals, 1,181 (51.5%) completed a COVID-19 vaccine series by delivery. Pregnant individuals were less likely to be vaccinated than the San Francisco population throughout the study period. Factors associated with lower vaccination rates in pregnant individuals included public insurance (AOR=0.21, 95% CI=0.16, 0.27), younger age (AOR=0.74, 95% CI=0.64, 0.86), English language preference (AOR=0.58, 95% CI=0.42, 0.80), and self-identified Black (AOR=0.26, 95% CI=0.17, 0.40) (ref: White), Hispanic (AOR=0.61, 95% CI=0.46, 0.81), or other (AOR=0.50, 95% CI=0.36, 0.68) race or ethnicity.</div></div><div><h3>Conclusions</h3><div>COVID-19 vaccination coverage among pregnant people in San Francisco lagged behind that of the city's similarly aged population, particularly among those with public insurance and of non-White race. Despite locally high vaccine acceptance, additional efforts are needed to address barriers and reduce disparities in COVID-19 vaccination within the pregnant population.</div></div>","PeriodicalId":72142,"journal":{"name":"AJPM focus","volume":"4 3","pages":"Article 100303"},"PeriodicalIF":0.0,"publicationDate":"2024-11-22","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143140255","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}